Challenges in the treatment of Rheumatoid Arthritis.
作者： Paola Conigliaro , Paola Triggianese , Erica De Martino , Giulia Lavinia Fonti , Maria Sole Chimenti
DOI: 10.1016/J.AUTREV.2019.05.007
关键词:
摘要: … Some patients are difficult to treat and do not reach the treatment targets as clinical … may concur to the treatment failure. In this review we aimed at identify difficult to treat RA patients and …
sci-hub.se 参考文章(141)
Isabela Silosi, Inimioara Mihaela Cojocaru, Camelia Doina Vrabie, R Tanasescu, Manole Cojocaru, Extra-articular Manifestations in Rheumatoid Arthritis Maedica. ,vol. 5, pp. 286- 291 ,(2010)
Sebastien Viatte, Anne Barton, The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease European Musculoskeletal Review. 2012;7(2):102-107.. ,vol. 7, pp. 102- 107 ,(2012)
W. K. Eddie Ip, Ruslan Medzhitov, Macrophages monitor tissue osmolarity and induce inflammatory response through NLRP3 and NLRC4 inflammasome activation Nature Communications. ,vol. 6, pp. 6931- 6931 ,(2015) , 10.1038/NCOMMS7931
Maria Sole Chimenti, Paola Triggianese, Paola Conigliaro, Matteo Santoro, Ramona Lucchetti, Roberto Perricone, Self-Reported Adherence to a Home-Based Exercise Program Among Patients Affected by Psoriatic Arthritis with Minimal Disease Activity Drug Development Research. ,vol. 75, pp. S57- S59 ,(2014) , 10.1002/DDR.21197
Yan He, Yuan Yue, Xi Zheng, Kun Zhang, Shaohua Chen, Zhiyun Du, Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. ,vol. 20, pp. 9183- 9213 ,(2015) , 10.3390/MOLECULES20059183
Hui Cai, Zhaoling Zheng, Yanhua Sun, Ziliang Liu, Mingqin Zhang, Chunqing Li, The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats. Drug Design Development and Therapy. ,vol. 9, pp. 4931- 4942 ,(2015) , 10.2147/DDDT.S90147
Paola Conigliaro, Paola Triggianese, Francesco Ippolito, Ramona Lucchetti, Maria Sole Chimenti, Roberto Perricone, Insights on the Role of Physical Activity in Patients with Rheumatoid Arthritis Drug Development Research. ,vol. 75, pp. S54- S56 ,(2014) , 10.1002/DDR.21196
Eleonora Ballanti, Paola Conigliaro, Maria Sole Chimenti, Barbara Kroegler, Gioia Di Muzio, Maria Domenica Guarino, Paola Triggianese, Gianfranco Gigliucci, Lucia Novelli, Carmen Barbato, Roberto Perricone, Use of Anti-Tumor Necrosis Factor Alpha Therapy in Patients with Concurrent Rheumatoid Arthritis and Hepatitis B or Hepatitis C: A Retrospective Analysis of 32 Patients Drug Development Research. ,vol. 75, pp. S42- S45 ,(2014) , 10.1002/DDR.21193
Roy M. Fleischmann, Nemanja S. Damjanov, Alan J. Kivitz, Anna Legedza, Thomas Hoock, Nils Kinnman, A Randomized, Double‐Blind, Placebo‐Controlled, Twelve‐Week, Dose‐Ranging Study of Decernotinib, an Oral Selective JAK‐3 Inhibitor, as Monotherapy in Patients With Active Rheumatoid Arthritis Arthritis & Rheumatism. ,vol. 67, pp. 334- 343 ,(2015) , 10.1002/ART.38949
Mark C. Genovese, Ronald F. van Vollenhoven, César Pacheco-Tena, Yanqiong Zhang, Nils Kinnman, VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis Arthritis & Rheumatism. ,vol. 68, pp. 46- 55 ,(2016) , 10.1002/ART.39473